ZZPZH(SH:600436)2015-01-20 16:00Financial Performance - Total operating revenue for 2014 was CNY 143,485.15 million, an increase of 2.79% compared to the previous year[3] - Operating profit reached CNY 50,834.31 million, reflecting a growth of 2.35% year-on-year[3] - Net profit attributable to shareholders was CNY 43,968.78 million, up by 2.31% from the previous year[3] - Basic earnings per share remained stable at CNY 2.73[3] - The weighted average return on net assets decreased by 5.26 percentage points to 16.66%[3] Assets and Equity - Total assets at the end of the reporting period were CNY 376,564.55 million, a 15.54% increase from the beginning of the year[3] - Shareholders' equity attributable to the parent company increased by 20.44% to CNY 301,849.87 million[3] Investment and Business Segments - The company experienced a significant increase in investment income due to the sale of part of its available-for-sale financial assets, specifically shares of Industrial Securities[6] - The pharmaceutical business saw a decline in performance, while the cosmetics segment experienced substantial growth[6] Accounting Policies - The company is in the process of assessing the impact of changes in accounting policies related to employee benefits, with no significant effect expected on current financial results[5]